These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23680959)

  • 1. Bioresorbable drug-eluting magnesium-alloy scaffold: design and feasibility in a porcine coronary model.
    Wittchow E; Adden N; Riedmüller J; Savard C; Waksman R; Braune M
    EuroIntervention; 2013 Apr; 8(12):1441-50. PubMed ID: 23680959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine model.
    Shen L; Wu Y; Ge L; Zhang Y; Wang Q; Qian J; Qiu Z; Ge J
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1473-1481. PubMed ID: 28639098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries: Insights From In Vivo Angiography, Ex Vivo Assessment, and Gene Analysis at the Stented/Scaffolded Segments and the Proximal and Distal Edges.
    Gogas BD; Benham JJ; Hsu S; Sheehy A; Lefer DJ; Goodchild TT; Polhemus DJ; Bouchi YH; Hung OY; Yoo SY; Joshi U; Giddens DP; Veneziani A; Quyyumi A; Rapoza R; King SB; Samady H
    JACC Cardiovasc Interv; 2016 Apr; 9(7):728-41. PubMed ID: 27056313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Characterization of Biomechanical Behavior and Healing Profile of a Novel Ultra-High-Molecular-Weight Amorphous Poly-l-Lactic Acid Sirolimus-Eluting Bioresorbable Coronary Scaffold.
    Cheng Y; Gasior P; Shibuya M; Ramzipoor K; Lee C; Estrada EA; Dokko D; McGregor JC; Conditt GB; Kaluza GL; Granada JF
    Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27694138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.
    Koppara T; Joner M; Bayer G; Steigerwald K; Diener T; Wittchow E
    Thromb Haemost; 2012 Jun; 107(6):1161-71. PubMed ID: 22535188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice.
    Farooq V; Serruys PW; Heo JH; Gogas BD; Onuma Y; Perkins LE; Diletti R; Radu MD; Räber L; Bourantas CV; Zhang Y; van Remortel E; Pawar R; Rapoza RJ; Powers JC; van Beusekom HM; Garcìa-Garcìa HM; Virmani R
    JACC Cardiovasc Interv; 2013 May; 6(5):523-32. PubMed ID: 23702016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
    Chevalier B; Silber S; Park SJ; Garcia E; Schuler G; Suryapranata H; Koolen J; Hauptmann KE; Wijns W; Morice MC; Carrie D; van Es GA; Nagai H; Detiege D; Paunovic D; Serruys PW;
    Circ Cardiovasc Interv; 2009 Jun; 2(3):188-95. PubMed ID: 20031715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of local intracoronary paclitaxel delivery using the Remedy transport catheter on neointimal hyperplasia after stent implantation in a porcine model.
    Milewski K; Zurakowski A; Pajak J; Liszka L; Debinski M; Buszman PP; Samra MA; Dominek P; Aboodi MS; Kaluza GL; Buszman P
    Cardiovasc Revasc Med; 2011; 12(2):82-9. PubMed ID: 21421185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year longitudinal evaluation of a second-generation thin-strut sirolimus-eluting bioresorbable coronary scaffold with hybrid cell design in porcine coronary arteries.
    Gasior P; Cheng Y; Xia J; Conditt GB; McGregor JC; Virmani R; Granada JF; Kaluza GL
    Cardiol J; 2020; 27(2):115-125. PubMed ID: 30155861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Biomechanical Behavior and Healing Profile of a Novel Thinned Wall Ultrahigh Molecular Weight Amorphous Poly-l-Lactic Acid Sirolimus-Eluting Bioresorbable Coronary Scaffold.
    Cheng Y; Gasior P; Xia JG; Ramzipoor K; Lee C; Estrada EA; Dokko D; McGregor JC; Conditt GB; McAndrew T; Kaluza GL; Granada JF
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of low-dose paclitaxel utilizing the cobra-P drug-eluting stent system with a novel biodegradable coating in de novo coronary lesions: the PLUS-ONE first-in-man study.
    Calderas C; Condado JF; Condado JA; Flores A; Mueller A; Thomas J; Nakatani D; Honda Y; Waseda K; Fitzgerald P
    Cardiovasc Revasc Med; 2014 Jan; 15(1):18-22. PubMed ID: 24315045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform.
    Thompson CA; Huibregtse B; Poff B; Wilson GJ
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):597-604. PubMed ID: 19180652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model.
    Otsuka F; Pacheco E; Perkins LE; Lane JP; Wang Q; Kamberi M; Frie M; Wang J; Sakakura K; Yahagi K; Ladich E; Rapoza RJ; Kolodgie FD; Virmani R
    Circ Cardiovasc Interv; 2014 Jun; 7(3):330-42. PubMed ID: 24895447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial 2-dimensional and 3-dimensional optical coherence tomography assessment of overhanging struts of drug-eluting absorbable metal scaffold: "DREAMS" for jailed side branch?
    Muramatsu T; García-García HM; Serruys PW; Waksman R; Verheye S;
    JACC Cardiovasc Interv; 2014 May; 7(5):575-6. PubMed ID: 24852807
    [No Abstract]   [Full Text] [Related]  

  • 17. Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model.
    Waksman R; Zumstein P; Pritsch M; Wittchow E; Haude M; Lapointe-Corriveau C; Leclerc G; Joner M
    EuroIntervention; 2017 Jul; 13(4):440-449. PubMed ID: 28262623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-induced arterial wall toxicity and inflammation: tissue uptake in various dose densities in a minipig model.
    Radeleff B; Lopez-Benitez R; Stampfl U; Stampfl S; Sommer C; Thierjung H; Berger I; Kauffmann G; Richter GM
    J Vasc Interv Radiol; 2010 Aug; 21(8):1262-70. PubMed ID: 20656224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-induced arterial wall toxicity and inflammation: part 2--long-term tissue response in a minipig model.
    Stampfl U; Radeleff B; Sommer C; Stampfl S; Lopez-Benitez R; Thierjung H; Kurz P; Berger I; Richter GM
    J Vasc Interv Radiol; 2009 Dec; 20(12):1608-16. PubMed ID: 19944986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects on vascular healing of bare metal stents delivered via paclitaxel-coated balloons in the porcine model of restenosis.
    Cremers B; Milewski K; Clever YP; Aboodi MS; Biedermann M; Thim T; Kelsch B; Kaluza GL; Scheller B; Granada JF
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):603-10. PubMed ID: 22511557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.